Your browser doesn't support javascript.
loading
High-throughput, targeted MHC class I immunopeptidomics using a functional genetics screening platform.
Bruno, Peter M; Timms, Richard T; Abdelfattah, Nouran S; Leng, Yumei; Lelis, Felipe J N; Wesemann, Duane R; Yu, Xu G; Elledge, Stephen J.
Afiliação
  • Bruno PM; Department of Genetics, Harvard Medical School and Division of Genetics, Brigham and Women's Hospital, Boston, MA, USA.
  • Timms RT; Howard Hughes Medical Institute, Chevy Chase, MD, USA.
  • Abdelfattah NS; Department of Genetics, Harvard Medical School and Division of Genetics, Brigham and Women's Hospital, Boston, MA, USA.
  • Leng Y; Howard Hughes Medical Institute, Chevy Chase, MD, USA.
  • Lelis FJN; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, University of Cambridge, Cambridge, UK.
  • Wesemann DR; Department of Genetics, Harvard Medical School and Division of Genetics, Brigham and Women's Hospital, Boston, MA, USA.
  • Yu XG; Howard Hughes Medical Institute, Chevy Chase, MD, USA.
  • Elledge SJ; Department of Genetics, Harvard Medical School and Division of Genetics, Brigham and Women's Hospital, Boston, MA, USA.
Nat Biotechnol ; 41(7): 980-992, 2023 Jul.
Article em En | MEDLINE | ID: mdl-36593401

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antígenos de Histocompatibilidade Classe I / Cisteína Tipo de estudo: Diagnostic_studies / Screening_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antígenos de Histocompatibilidade Classe I / Cisteína Tipo de estudo: Diagnostic_studies / Screening_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article